The Efficacy of Peripheral Opioid Antagonists in Opioid-Induced Constipation and Postoperative Ileus: A Systematic Review of the Literature

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Regional anesthesia and pain medicine

• Publication date

  2017-06-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/AAP.0000000000000671PMID 29016552
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidural Local Anesthetics Versus Opioid-Based Analgesic Regimens for Postoperative Gastrointestinal Paralysis, Vomiting, and Pain After Abdominal Surgery.

  2019cited by this paper
• Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis

  2018cited by this paper
• Randomized, Double‐Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid‐Induced Constipation in Patients with Chronic Noncancer Pain

  2017influential reference
• The role of naloxegol in the management of opioid-induced bowel dysfunction

  2016cited by this paper
• Epidural local anaesthetics versus opioid-based analgesic regimens for postoperative gastrointestinal paralysis, vomiting and pain after abdominal surgery.

  2016cited by this paper
• Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review

  2016cited by this paper
• Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid‐Induced Constipation: A Responder Analysis of 2 Randomized, Placebo‐Controlled Trials

  2015cited by this paper
• Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction

  2015cited by this paper
• Fixed-Dose Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: Results of a Randomized, Placebo-Controlled Study and Open-Label Extension

  2015cited by this paper
• Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery.

  2015cited by this paper
• Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain

  2015cited by this paper
• Naloxegol for opioid-induced constipation in patients with noncancer pain.

  2014cited by this paper
• Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid‐induced constipation

  2014cited by this paper
• Opioid-induced bowel dysfunction: epidemiology, pathophysiology, diagnosis, and initial therapeutic approach.

  2014influential reference
• Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial.

  2014cited by this paper
• Defining Postoperative Ileus: Results of a Systematic Review and Global Survey

  2013cited by this paper
• Randomized placebo-controlled study of intravenous methylnaltrexone in postoperative ileus

  2013cited by this paper
• Efficacy of Pharmacological Therapies for the Treatment of Opioid-Induced Constipation: Systematic Review and Meta-Analysis

  2013cited by this paper
• A phase 2, double‐blind, randomized, placebo‐controlled, dose‐escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid‐induced constipation

  2013cited by this paper
• Subcutaneous methylnaltrexone for treatment of acute opioid-induced constipation: phase 2 study in rehabilitation after orthopedic surgery.

  2012cited by this paper
• Opioid-Induced Bowel Dysfunction

  2012cited by this paper
• A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.

  2011cited by this paper
• Preferred reporting items of systematic review and meta-analyses: the PRISMA statement

  2011cited by this paper
• Safety and Efficacy of Methylnaltrexone in Shortening the Duration of Postoperative Ileus Following Segmental Colectomy: Results of Two Randomized, Placebo-Controlled Phase 3 Trials

  2011cited by this paper
• Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.

  2011cited by this paper
• A randomized, placebo-controlled phase 3 trial (Study SB-767905/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.

  2011cited by this paper
• Anesthetic Routines: The Anesthesiologist's Role in GI Recovery and Postoperative Ileus

  2010cited by this paper
• Pathogenesis and clinical and economic consequences of postoperative ileus

  2010cited by this paper
• The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health

  2010cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Trends in long‐term opioid therapy for chronic non‐cancer pain

  2009cited by this paper
• Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.

  2009cited by this paper
• Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

  2009cited by this paper
• Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.

  2009cited by this paper
• Neuroimmune mechanisms in postoperative ileus

  2009cited by this paper
• Peripherally Acting Mu-Opioid Receptor Antagonists and Postoperative Ileus: Mechanisms of Action and Clinical Applicability

  2009cited by this paper
• New drug to restore bowel function approved under new FDA rules.

  2008cited by this paper
• Clinical trial: alvimopan for the management of post‐operative ileus after abdominal surgery: results of an international randomized, double‐blind, multicentre, placebo‐controlled clinical study

  2008cited by this paper
• Methylnaltrexone for opioid-induced constipation in advanced illness.

  2008cited by this paper
• Methylnaltrexone for opioid-induced constipation in advanced illness.

  2008cited by this paper
• Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway.

  2008cited by this paper
• Alvimopan, a peripherally acting mu‐opioid receptor (PAM‐OR) antagonist for the treatment of opioid‐induced bowel dysfunction: Results from a randomized, double‐blind, placebo‐controlled, dose‐finding study in subjects taking opioids for chronic non‐cancer pain

  2008cited by this paper
• Pathogenesis and clinical and economic consequences of postoperative ileus.

  2007cited by this paper
• Novel Opioid Antagonists for Opioid-Induced Bowel Dysfunction and Postoperative Ileus

  2007cited by this paper
• Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery

  2006cited by this paper
• A double-blind, randomized, placebo-controlled phase III study of the safety of alvimopan in patients who undergo simple total abdominal hysterectomy.

  2006cited by this paper
• Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study.

  2005cited by this paper
• Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial.

  2005cited by this paper
• Phase III Trial of Alvimopan, a Novel, Peripherally Acting, Mu Opioid Antagonist, for Postoperative Ileus After Major Abdominal Surgery

  2005cited by this paper
• Alvimopan, a Novel, Peripherally Acting μ Opioid Antagonist: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Major Abdominal Surgery and Postoperative Ileus

  2004cited by this paper
• Grading quality of evidence and strength of recommendations

  2004cited by this paper
• Opioids in chronic non‐cancer pain: systematic review of efficacy and safety

  2004cited by this paper
• Selective postoperative inhibition of gastrointestinal opioid receptors.

  2002cited by this paper
• Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial.

  2002cited by this paper
• Low-dose oral naloxone reverses opioid-induced constipation and analgesia.

  2002cited by this paper
• Selective postoperative inhibition of gastrointestinal opioid receptors.

  2001cited by this paper
• Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.

  2000influential reference
• Methylnaltrexone prevents morphine‐induced delay in oral‐cecal transit time without affecting analgesia: A double‐blind randomized placebo‐controlled trial

  1996cited by this paper

• Mechanisms and Management of Ileus.

  2025cites this paper
• Sigma-1 receptor antagonism as a promising strategy for postoperative pain treatment: A study in laparotomized mice.

  2025cites this paper
• Postoperative Darmpassage-Störungen in der Intensivmedizin

  2025cites this paper
• Effects of naloxegol on transit recovery in patients undergoing cardiac surgery: A randomized, double-blind, placebo-controlled trial.

  2025cites this paper
• Gastrointestinal Bleeds Are a Rare Event After Total Hip and Knee Arthroplasty.

  2025cites this paper
• Influence of Certification Program on Treatment Quality and Survival for Rectal Cancer Patients in Germany: Results of 13 Certified Centers in Collaboration with AN Institute

  2024cites this paper
• Gastrointestinal complications after fast-track total hip and knee replacement: an observational study in a consecutive 36,932 patient cohort

  2023cites this paper
• Management of Constipation in Hospitalized Patients

  2023cites this paper
• Postoperative Handheld Gastric Point-of-Care Ultrasound and Delayed Bowel Function.

  2023cites this paper
• Opioids

  2022cites this paper
• Intravenous lidocaine simultaneously infused with sufentanil to accelerate gastrointestinal function recovery in patients after thoracolumbar surgery: a prospective, randomized, double-blind controlled study

  2022cites this paper
• Comparison of Postoperative Gastrointestinal Motility of Sugammadex and Neostigmine in Patients Undergoing Robotic Thyroidectomy: A Retrospective Study

  2022cites this paper
• A Role for Gastric Point of Care Ultrasound in Postoperative Delayed Gastrointestinal Functioning.

  2022cites this paper
• Prevention and Management of Postoperative Ileus: A Review of Current Practice

  2022cites this paper
• Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction

  2022cites this paper
• Effects of Reversal Technique for Neuromuscular Paralysis on Time to Recovery of Bowel Function after Craniotomy

  2022cites this paper
• Risk factors of postoperative ileus following laparoscopic radical cystectomy and developing a points-based risk assessment scale

  2021cites this paper
• Perioperative Pain Management and Opioid Stewardship: A Practical Guide

  2021cites this paper
• The effect of opioids on gastrointestinal function in the ICU

  2021cites this paper
• Design and feasibility of a double-blind, randomized trial of peri-operative methylnaltrexone for postoperative ileus prevention after adult spinal arthrodesis.

  2021cites this paper
• Risk Factors for 30- and 90-Day Readmission due to Intestinal Bowel Obstruction after Posterior Lumbar Fusion

  2020cites this paper
• Endoscopic ultrasound: a powerful tool to modify treatment algorithms in opioid-induced achalasia

  2020cites this paper
• Enhanced Recovery After Surgery (ERAS)

  2020cites this paper
• Ileus

  2020cites this paper
• Peripherally Acting μ-Opioid Receptor Antagonists in the Management of Postoperative Ileus: a Clinical Review

  2020cites this paper
• Methadone-based Multimodal Analgesia Provides the Best-in-class Acute Surgical Pain Control and Functional Outcomes With Lower Opioid Use Following Major Posterior Fusion Surgery in Adolescents With Idiopathic Scoliosis

  2020cites this paper
• Opioid-induced Constipation

  2020cites this paper
• A Review of Enhanced Recovery Protocols in Pelvic Surgery

  2020cites this paper
• The association between N-methylnaltrexone, a peripherally acting mu-opioid receptor antagonist, and clinical outcomes in patients undergoing robotic-assisted radical cystectomy

  2020cites this paper
• Effects of Sugammadex on Time of First Postoperative Bowel Movement

  2019cites this paper
• Enhanced recovery pathways in colorectal surgery: a consensus paper by the Associazione Chirurghi Ospedalieri Italiani (ACOI) and the PeriOperative Italian Society (POIS).

  2019cites this paper
• Preoperative instructions and postoperative care in the 21 st century

  2019cites this paper
• Naloxegol para el tratamiento del estreñimiento inducido por opioides: un estudio descriptivo de seguimiento anual en tres pacientes con dolor crónico por cáncer

  2019cites this paper
• An update on the safety of prescribing opioids in pediatrics

  2019cites this paper
• Enhanced recovery after rectal surgery: what we have learned so far

  2018cites this paper
• Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations: 2018

  2018cites this paper
• Updates in the Management of Postoperative Nausea and Vomiting.

  2018cites this paper
• Evaluation of the Effect of Oral Pyridostigmine on the Ileus after Abdominal Surgery: A Blinded Randomized Clinical Trial

  2018cites this paper
• Methylnaltrexone bromide for the treatment of opioid-induced constipation

  2018cites this paper
• Reply to Dr Nair: When it Comes to Novel Opioids, Any Claims Must Be Supported by Data

  2017cites this paper
• Stellate Ganglion Block Is Beneficial During Induced Acute Myocardial Ischemia in Rats: Can Experimental Data Encourage Human Use (Again)?

  2017cites this paper
• Opioid With Minimal or No Peripheral Adverse Effects: Myth or Reality?

  2017cites this paper
• Commentary: Defecation Delay in Patients After Lung Tumor Surgery: A Prospective Nested Case-Control Study

  year unknowncites this paper